The Story of RU-486 in the United States

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Pinho, Elizabeth	en_US
dc.date.accessioned	2012-06-15T20:29:51Z
dc.date.issued	2001	en_US
dc.identifier.citation	The Story of RU-486 in the United States (2001 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8889480
dc.description.abstract	In this paper, I will navigate you through the fascinating odyssey of RU-486 from its initial development in France to its official entry into the U.S. pharmaceutical market to the post-approval strife in which it is now embroiled. While many assumed that the FDAâ€™s approval of RU-486 on September 28, 2000 would mark the final chapter in the story of the drugâ€™s acceptance as an early pregnancy termination procedure, it actually marked the beginning of a new chapter, which ignited congressional efforts to stymie, or even abort, the growth of this chemical alternative to surgical abortion in the United States. As a result of these congressional efforts, the last chapter in the story of RU-486 remains to be written.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	RU-486	en
dc.subject	abortion pill	en
dc.subject	FDA	en
dc.title	The Story of RU-486 in the United States	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-15T20:29:51Z